tesamorelin or retatrutide (Reta GLP-3) - 99%+ Purity Retatrutide, Tesamorelin, and Ipamorelin: A

Short-acting GLP-1 agonists like exenatide (taken twice daily) may produce more immediate effects on post-meal glucose levels, whilst longer-acting weekly formulations such as semaglutide or dulaglutide provide more sustained action but may take longer to reach steady-state concentrations in the body

This guide separates what the research supports from what remains promising but unproven

Pure Tested Peptides provides thoroughly tested compounds that meet research-grade standards, ensuring consistency across study protocols

If you have taken your injection early and experience any unusual or severe symptoms, contact your GP or NHS 111 for advice